Israel is, quite literally, where modern cannabis science began — and it remains one of the world’s most important centers for medical cannabis research and treatment. It was an Israeli scientist who first isolated THC in the 1960s, and the country has since built a sophisticated medical-cannabis program, a thriving research sector and a leading role in the global industry. Yet recreational use remains illegal. Understanding Israel means understanding how a nation became a scientific and medical powerhouse for cannabis while holding the line on recreational prohibition. Here is the full story. First, our cannabis glossary explains the key terms.
The birthplace of cannabis science
Israel’s cannabis story starts with research. In the 1960s, Israeli chemist Raphael Mechoulam and colleagues first isolated and described THC, the main psychoactive compound in cannabis, and later helped uncover the endocannabinoid system — the network in the human body that cannabinoids act upon. This foundational work made Israel the intellectual birthplace of modern cannabis science, and it established a research culture that has kept the country at the forefront of the field for decades. That scientific heritage underpins everything about Israel’s cannabis role today. For the global picture, see our International desk.
A pioneering medical program
Israel built one of the world’s earliest and most established medical cannabis programs. The country began allowing medical cannabis for patients decades ago, developing a regulated system overseen by health authorities in which eligible patients can receive cannabis for a range of conditions. Over time the program matured, with structured licensing, quality standards and a substantial patient population. This long track record gave Israel unusually deep clinical experience with medical cannabis, informing treatment protocols that other countries have studied and adapted. Our Learn section explores the medical science behind these uses.
How the medical system works
Israel’s medical cannabis operates through a regulated framework in which patients obtain authorization for cannabis treatment, and products are supplied through licensed channels under health-ministry oversight. The country has worked to standardize products, improve quality control and integrate cannabis into medical practice more formally than many nations. Reforms over the years aimed to expand access, streamline prescribing and strengthen the pharmaceutical-grade nature of the supply. The result is a mature, medically integrated system rather than the loose or hard-to-access arrangements seen in some other countries. Detailed guidance comes from Israel’s health authorities.
A global research hub
Beyond treatment, Israel is a powerhouse of cannabis research and innovation. Universities, hospitals and companies conduct extensive clinical studies, and the country has become a magnet for cannabis research collaborations and investment from around the world. This research ecosystem — combining scientific expertise, clinical infrastructure and supportive policy for medical study — has produced a steady stream of knowledge about cannabis’s medical applications. For the global industry, Israel functions as a kind of research-and-development center, punching far above its size in scientific output.
The recreational line
Despite its medical and scientific leadership, Israel has not legalized recreational cannabis. Recreational use remains illegal, though enforcement and public attitudes have shifted over time, and there have been periods of debate and proposals around decriminalization or reform. Personal possession has at times been treated more leniently, but the fundamental legal position is that recreational use is not permitted. This creates the characteristic Israeli split: world-leading on medical and scientific cannabis, conservative on recreational use — a distinction central to understanding the country. Our news coverage tracks reform debates.
The reform debate
Israel has repeatedly debated loosening its recreational rules, with proposals for decriminalization or a regulated model surfacing in its politics. Public opinion has grown more open, and the country’s deep medical experience is sometimes cited as a foundation for broader reform. However, political complexity and shifting governments have meant that recreational legalization has not been enacted. As of early 2025, the recreational question remained unresolved, even as the medical and research sectors continued to thrive. It is a live debate in a country uniquely equipped to inform it.
The export and industry role
Israel has positioned itself as a significant player in the global medical-cannabis industry, developing cultivation, research and export capabilities. Its combination of scientific credibility, clinical data and regulated production makes Israeli cannabis expertise valuable internationally, and the country has pursued export opportunities to supply medical markets abroad. This industrial dimension complements its research role, turning scientific leadership into economic activity and reinforcing Israel’s outsized influence on the worldwide cannabis sector.
Why Israel matters globally
Israel’s importance to the cannabis world is disproportionate to its size. As the birthplace of cannabis science, a pioneer of medical programs, and a hub of ongoing research, it has shaped global understanding of the plant’s therapeutic potential. Countries designing medical-cannabis systems frequently draw on Israeli research and experience. When the world debates the medical merits of cannabis, much of the underlying science traces back to Israeli laboratories — a legacy that gives the country lasting influence over how cannabis is understood and used medically everywhere.
What patients and visitors should know
For patients, Israel offers one of the more established medical-cannabis systems, accessible through its regulated framework for eligible conditions. For visitors, the key point is that recreational use remains illegal, and tourists should not expect legal recreational access despite the country’s medical prominence. As everywhere, carrying cannabis across Israel’s borders is illegal regardless of domestic rules. The realistic picture is a medically advanced but recreationally restricted environment, and travelers should plan accordingly and respect local law.
Where Israel sits globally
Israel is not among the nine countries that fully legalized recreational cannabis in widely cited global tallies, but it ranks among the most significant medical and research nations anywhere. Its influence flows through science and medicine rather than recreational policy. For deeper background, the overview of medical cannabis in Israel traces the country’s pioneering program and research legacy.
The bottom line
Israel is the scientific cradle of modern cannabis: the place where THC was first isolated and the endocannabinoid system understood, home to a pioneering medical program and a world-leading research sector. Yet recreational use remains illegal, producing a striking split between medical leadership and recreational caution. For patients, Israel is a medically advanced destination; for the world, it is where much of what we know about cannabis medicine originates. As always, verify current rules before acting, and never carry cannabis across borders. This article is informational, for adults of legal age; verify local legality before acting on it.
